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Abstract
Production of high-quality spermatozoa is necessary for male fertility. In this regard, post-mitotic stage in spermatogenesis is very
important which posttranscriptional microRNAs (miRNAs) playing a key role at this stage. In this research, we evaluated the
expression and methylation of hsa-miR-34 family in sperm samples of infertile men. We recruited 102 infertile men (astheno-
zoospermia, teratozoospermia, asthenoteratozoospermia, and oligoasthenoteratozoospermia) and 52 fertile men as control. The
expression of hsa-miR-34a,b,c was determined by quantitative real-time PCR (qRT-PCR) technique. Methylation of hsa-miR-
34b,c promoter was evaluated by methylation-specific PCR (MS-PCR) method. Our data indicated under-expression of three
miRNAs (hsa-miR-34a,b,c) in the sperm samples of infertile men in compared to their fertile counterparts. The highest rate of
expression reduction was observed in hsa-miR-34c-5p and in oligoasthenoteratospermic patients (P = 0.011, F = 4.01). The
results revealed that the frequency of methylation of the promoter region of hsa-miR-34b,c in infertile men was higher than that
of fertile men (82.4% versus 23.3%), and the highest frequency of methylation was observed in patients with
asthenoteratospermia (92.9%) and oligoasthenoteratospermia (93.8%). In conclusion, our results indicated lower expression of
hsa-miR-34a,b,c and hypermethylation of hsa-miR-34b,c promoter in sperm samples of infertile men. Aberrant under-expression
of these miRNAs could be duo to the hypermethylation of the promoter region and indicative of a defect in spermatogenesis.
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Introduction
Infertility usually afflicts 10–15% of couples [1] and 50% of
infertility is related to male factor. Meanwhile, 60–75% of
infertility in men are idiopathic, and the precise mechanism
for its occurrence is unclear [ 1]. Many genetic factors inter-
fere with male infertility, among which Yq microdeletion and
chromosomal aberration are the main causes of impaired sper-
matogenesis and male infertility [2].
On the other hand, the role of microRNAs (miRNAs) in
male infertility has been highlighted these days. miRNAs are
small (18–25 nt) RNAs categorized as noncoding RNAs, and
their function is to regulate gene expression [3]. They have
close to 90% sequence homology among the human, mouse,
and rat. [4] miRNAs control the gene expression in two ways:
by suppressing translation/transcription (RNAi) [5]or by acti-
vating transcription (RNAa). [6] The results of computational
analyses have indicated the presence of 50,000 miRNAs in
mammalian cells, where eachmiRNA regulates a great deal of
mRNA expression [7].
In this way, they control the expression of many genes and
have a vital role in important cellular processes such as devel-
opment, differentiation, apoptosis, and proliferation processes
in various species [3, 5, 7, 8]. Studies have suggested that
miRNAs are involved in different stages of male germ cell
development, where some of their expression is limited to
certain types of male germ cells, while the others are
expressed in different cell types of the testes [9–11].
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